Product Code: 141
Global bioreactors market is set to witness substantial growth between 2023 and 2032 primarily owing to the technological advancements in bioreactors. Increasing adoption of single-use bioreactors owing to their additional benefits like efficiency in air and gas transfer, proper mixing of cells, and flexible operating conditions for better results will fuel the product demand in near future.
Overall, the bioreactors market has been bifurcated in terms of product, molecule, end-user, cell, usage, and region.
Based on product, the bioreactors market is likely to be characterized by the single-use segment. This segment is likely to grow at 15.5% CAGR through the estimated timeframe owing to the increasing adoption of single-use bioreactors for research purposes and to produce vaccines for a range of infections including COVID-19. Besides, it comes with a range of benefits for the researchers as well which is likely propel its demand in the upcoming times.
On the basis of molecule, the stem cells segment is likely to grow at more than 12.5% CAGR over 2023-2032. There is a widespread adoption of stem cell therapy due to an increase in the number of cancer cases. Furthermore, supportive government initiatives, increasing R&D expenditure, and rising demand for cell-based products are likely to fuel the segmental expansion of stem cell-based products in the future.
In the context of end-user, the biopharma manufacturers segment is poised to witness substantial growth. This can be credited to the rising adoption of advanced technologies which can be used to ease complex manufacturing.
Within the category of cells, the bioreactors market will be driven by the bacterial cells segment. Bacterial cells are used to produce several pharmaceutical therapeutics. Increasing usage of them by research institutes and manufacturers will positively drive the market growth through the analysis timespan.
Based on usage, the bioreactor market is likely to be driven by the commercial production segment. This segment will witness substantial growth due to the increasing burden of chronic diseases, introduction of new companies, and mass production of vaccines. Moreover, reusable bioreactors are cost-effective and convenient which will also enhance the segmental revenue through the stipulated timeframe.
In the regional landscape, the bioreactors market in the MEA region will grow at a robust rate through the estimated timeframe. Increasing cases of infectious diseases in African countries along with the rising demand for drugs to cure them will likely bolster the market scenario in the upcoming time.
Some of the key players in the bioreactors market include Danaher Corporation, Thermo Fisher Scientific, Getinge (Applikon Biotechnology), CESCO Bioengineering Co. Ltd, Bbi Biotech, Shanghai Bailun Biotechnology co., Ltd., PBS Biotech, Pierre Guerin SAS (Engie), and Solaris Biotech Solutions.
Table of Contents
Chapter 1 Methodology & Scope
- 1.1 Methodology
- 1.2 Base estimates and working
- 1.2.1 North America
- 1.2.2 Europe
- 1.2.3 Asia Pacific
- 1.2.4 Latin America
- 1.2.5 MEA
- 1.3 Forecast parameters
- 1.4 Data validation
- 1.5 Data sources
- 1.5.1 Secondary
- 1.5.1.1 Paid sources
- 1.5.1.2 Unpaid sources
- 1.5.2 Primary
Chapter 2 Executive Summary
- 2.1 Bioreactors industry 360 degree synopsis, 2018 - 2032
- 2.1.1 Business trends
- 2.1.2 Product type trends
- 2.1.3 Cell trends
- 2.1.4 Molecule trends
- 2.1.5 Usage trends
- 2.1.6 End-use trends
- 2.1.7 Regional trends
Chapter 3 Bioreactors Industry Insights
- 3.1 Industry segmentation
- 3.2 Industry landscape, 2018 - 2032
- 3.3 Industry impact forces
- 3.3.1 Growth drivers
- 3.3.1.1 Growing pharmaceutical and biotechnology industry
- 3.3.1.2 Technological advancements in bioreactors
- 3.3.1.3 Growing focus on orphan drug development
- 3.3.1.4 Rising demand for personalized medicines
- 3.3.2 Industry pitfalls & challenges
- 3.3.2.1 Low capacity of single-use bioreactors
- 3.3.2.2 Concerns regarding extractables and/or leachables
- 3.4 Growth potential analysis
- 3.4.1 By product type
- 3.4.2 By cell
- 3.4.3 By molecule
- 3.4.4 By usage
- 3.4.5 By end-use
- 3.5 COVID- 19 impact analysis
- 3.6 Regulatory landscape
- 3.6.1 U.S.
- 3.6.2 Canada
- 3.6.3 Europe
- 3.6.4 China
- 3.7 Technology landscape
- 3.7.1 Technology overview of single-use bioreactors
- 3.7.1.1 Wave-induced motion SUB
- 3.7.1.2 Single-use bubble column
- 3.7.1.3 Stirred SUB
- 3.8 Porter's analysis
- 3.8.1 Bargaining power of suppliers
- 3.8.2 Bargaining power of buyers
- 3.8.3 Threat of new entrants
- 3.8.4 Threat of substitutes
- 3.8.5 Industry rivalry
- 3.9 PESTEL analysis
- 3.9.1 Political
- 3.9.2 Economical
- 3.9.3 Social
- 3.9.4 Technological
- 3.9.5 Environmental
- 3.9.6 Legal
Chapter 4 Competitive Landscape, 2021
- 4.1 Introduction
- 4.1.1 Engie Group
- 4.1.2 Thermo Fisher Scientific Inc.
- 4.1.3 Danaher Corporation
- 4.1.4 Merck KGaA
- 4.2 Company matrix analysis, 2021
- 4.3 Strategy dashboard, 2021
Chapter 5 Bioreactors Market, By Product Type
- 5.1 Key segment trends
- 5.2 Single-use
- 5.2.1 Market size, by region, 2018 - 2032 (USD Million)
- 5.3 Reusable
- 5.3.1 Market size, by region, 2018 - 2032 (USD Million)
Chapter 6 Bioreactors Market, By Cell
- 6.1 Key segment trends
- 6.2 Mammalian cells
- 6.2.1 Market size, by region, 2018 - 2032 (USD Million)
- 6.3 Bacterial cells
- 6.3.1 Market size, by region, 2018 - 2032 (USD Million)
- 6.4 Yeast cells
- 6.4.1 Market size, by region, 2018 - 2032 (USD Million)
- 6.5 Others
- 6.5.1 Market size, by region, 2018 - 2032 (USD Million)
Chapter 7 Bioreactors Market, By Molecule
- 7.1 Key segment trends
- 7.2 Monoclonal antibodies
- 7.2.1 Market size, by region, 2018 - 2032 (USD Million)
- 7.3 Vaccines
- 7.3.1 Market size, by region, 2018 - 2032 (USD Million)
- 7.4 Recombinant proteins
- 7.4.1 Market size, by region, 2018 - 2032 (USD Million)
- 7.5 Stem cells
- 7.5.1 Market size, by region, 2018 - 2032 (USD Million)
- 7.6 Gene therapy
- 7.6.1 Market size, by region, 2018 - 2032 (USD Million)
- 7.7 Others
- 7.7.1 Market size, by region, 2018 - 2032 (USD Million)
Chapter 8 Bioreactors Market, By Usage
- 8.1 Key segment trends
- 8.2 Developmental, pre-clinical & clinical
- 8.2.1 Market size, by region, 2018 - 2032 (USD Million)
- 8.3 Commercial production
- 8.3.1 Market size, by region, 2018 - 2032 (USD Million)
Chapter 9 Bioreactors Market, By End-use
- 9.1 Key segment trends
- 9.2 R&D organizations
- 9.2.1 Market size, by region, 2018 - 2032 (USD Million)
- 9.3 Biopharma manufacturers
- 9.3.1 Market size, by region, 2018 - 2032 (USD Million)
- 9.4 Contract manufacturing organizations (CMOs)
- 9.4.1 Market size, by region, 2018 - 2032 (USD Million)
Chapter 10 Bioreactors Market, By Region
- 10.1 Key regional trends
- 10.2 North America
- 10.2.1 Market size, by country, 2018 - 2032 (USD Million)
- 10.2.2 Market size, by product type, 2018 - 2032 (USD Million)
- 10.2.3 Market size, by cell, 2018 - 2032 (USD Million)
- 10.2.4 Market size, by molecule, 2018 - 2032 (USD Million)
- 10.2.5 Market size, by usage, 2018 - 2032 (USD Million)
- 10.2.6 Market size, by end-use, 2018 - 2032 (USD Million)
- 10.2.7 U.S.
- 10.2.7.1 Market size, by product type, 2018 - 2032 (USD Million)
- 10.2.7.2 Market size, by cell, 2018 - 2032 (USD Million)
- 10.2.7.3 Market size, by molecule, 2018 - 2032 (USD Million)
- 10.2.7.4 Market size, by usage, 2018 - 2032 (USD Million)
- 10.2.7.5 Market size, by end-use, 2018 - 2032 (USD Million)
- 10.2.8 Canada
- 10.2.8.1 Market size, by product type, 2018 - 2032 (USD Million)
- 10.2.8.2 Market size, by cell, 2018 - 2032 (USD Million)
- 10.2.8.3 Market size, by molecule, 2018 - 2032 (USD Million)
- 10.2.8.4 Market size, by usage, 2018 - 2032 (USD Million)
- 10.2.8.5 Market size, by end-use, 2018 - 2032 (USD Million)
- 10.3 Europe
- 10.3.1 Market size, by country, 2018 - 2032 (USD Million)
- 10.3.2 Market size, by product type, 2018 - 2032 (USD Million)
- 10.3.3 Market size, by cell, 2018 - 2032 (USD Million)
- 10.3.4 Market size, by molecule, 2018 - 2032 (USD Million)
- 10.3.5 Market size, by usage, 2018 - 2032 (USD Million)
- 10.3.6 Market size, by end-use, 2018 - 2032 (USD Million)
- 10.3.7 Germany
- 10.3.7.1 Market size, by product type, 2018 - 2032 (USD Million)
- 10.3.7.2 Market size, by cell, 2018 - 2032 (USD Million)
- 10.3.7.3 Market size, by molecule, 2018 - 2032 (USD Million)
- 10.3.7.4 Market size, by usage, 2018 - 2032 (USD Million)
- 10.3.7.5 Market size, by end-use, 2018 - 2032 (USD Million)
- 10.3.8 UK
- 10.3.8.1 Market size, by product type, 2018 - 2032 (USD Million)
- 10.3.8.2 Market size, by cell, 2018 - 2032 (USD Million)
- 10.3.8.3 Market size, by molecule, 2018 - 2032 (USD Million)
- 10.3.8.4 Market size, by usage, 2018 - 2032 (USD Million)
- 10.3.8.5 Market size, by end-use, 2018 - 2032 (USD Million)
- 10.3.9 France
- 10.3.9.1 Market size, by product type, 2018 - 2032 (USD Million)
- 10.3.9.2 Market size, by cell, 2018 - 2032 (USD Million)
- 10.3.9.3 Market size, by molecule, 2018 - 2032 (USD Million)
- 10.3.9.4 Market size, by usage, 2018 - 2032 (USD Million)
- 10.3.9.5 Market size, by end-use, 2018 - 2032 (USD Million)
- 10.3.10 Spain
- 10.3.10.1 Market size, by product type, 2018 - 2032 (USD Million)
- 10.3.10.2 Market size, by cell, 2018 - 2032 (USD Million)
- 10.3.10.3 Market size, by molecule, 2018 - 2032 (USD Million)
- 10.3.10.4 Market size, by usage, 2018 - 2032 (USD Million)
- 10.3.10.5 Market size, by end-use, 2018 - 2032 (USD Million)
- 10.3.11 Italy
- 10.3.11.1 Market size, by product type, 2018 - 2032 (USD Million)
- 10.3.11.2 Market size, by cell, 2018 - 2032 (USD Million)
- 10.3.11.3 Market size, by molecule, 2018 - 2032 (USD Million)
- 10.3.11.4 Market size, by usage, 2018 - 2032 (USD Million)
- 10.3.11.5 Market size, by end-use, 2018 - 2032 (USD Million)
- 10.3.12 The Netherlands
- 10.3.12.1 Market size, by product type, 2018 - 2032 (USD Million)
- 10.3.12.2 Market size, by cell, 2018 - 2032 (USD Million)
- 10.3.12.3 Market size, by molecule, 2018 - 2032 (USD Million)
- 10.3.12.4 Market size, by usage, 2018 - 2032 (USD Million)
- 10.3.12.5 Market size, by end-use, 2018 - 2032 (USD Million)
- 10.3.13 Denmark
- 10.3.13.1 Market size, by product type, 2018 - 2032 (USD Million)
- 10.3.13.2 Market size, by cell, 2018 - 2032 (USD Million)
- 10.3.13.3 Market size, by molecule, 2018 - 2032 (USD Million)
- 10.3.13.4 Market size, by usage, 2018 - 2032 (USD Million)
- 10.3.13.5 Market size, by end-use, 2018 - 2032 (USD Million)
- 10.4 Asia Pacific
- 10.4.1 Market size, by country, 2018 - 2032 (USD Million)
- 10.4.2 Market size, by product type, 2018 - 2032 (USD Million)
- 10.4.3 Market size, by cell, 2018 - 2032 (USD Million)
- 10.4.4 Market size, by molecule, 2018 - 2032 (USD Million)
- 10.4.5 Market size, by usage, 2018 - 2032 (USD Million)
- 10.4.6 Market size, by end-use, 2018 - 2032 (USD Million)
- 10.4.7 China
- 10.4.7.1 Market size, by product type, 2018 - 2032 (USD Million)
- 10.4.7.2 Market size, by cell, 2018 - 2032 (USD Million)
- 10.4.7.3 Market size, by molecule, 2018 - 2032 (USD Million)
- 10.4.7.4 Market size, by usage, 2018 - 2032 (USD Million)
- 10.4.7.5 Market size, by end-use, 2018 - 2032 (USD Million)
- 10.4.8 Japan
- 10.4.8.1 Market size, by product type, 2018 - 2032 (USD Million)
- 10.4.8.2 Market size, by cell, 2018 - 2032 (USD Million)
- 10.4.8.3 Market size, by molecule, 2018 - 2032 (USD Million)
- 10.4.8.4 Market size, by usage, 2018 - 2032 (USD Million)
- 10.4.8.5 Market size, by end-use, 2018 - 2032 (USD Million)
- 10.4.9 India
- 10.4.9.1 Market size, by product type, 2018 - 2032 (USD Million)
- 10.4.9.2 Market size, by cell, 2018 - 2032 (USD Million)
- 10.4.9.3 Market size, by molecule, 2018 - 2032 (USD Million)
- 10.4.9.4 Market size, by usage, 2018 - 2032 (USD Million)
- 10.4.9.5 Market size, by end-use, 2018 - 2032 (USD Million)
- 10.4.10 South Korea
- 10.4.10.1 Market size, by product type, 2018 - 2032 (USD Million)
- 10.4.10.2 Market size, by cell, 2018 - 2032 (USD Million)
- 10.4.10.3 Market size, by molecule, 2018 - 2032 (USD Million)
- 10.4.10.4 Market size, by usage, 2018 - 2032 (USD Million)
- 10.4.10.5 Market size, by end-use, 2018 - 2032 (USD Million)
- 10.4.11 Australia
- 10.4.11.1 Market size, by product type, 2018 - 2032 (USD Million)
- 10.4.11.2 Market size, by cell, 2018 - 2032 (USD Million)
- 10.4.11.3 Market size, by molecule, 2018 - 2032 (USD Million)
- 10.4.11.4 Market size, by usage, 2018 - 2032 (USD Million)
- 10.4.11.5 Market size, by end-use, 2018 - 2032 (USD Million)
- 10.4.12 Singapore
- 10.4.12.1 Market size, by product type, 2018 - 2032 (USD Million)
- 10.4.12.2 Market size, by cell, 2018 - 2032 (USD Million)
- 10.4.12.3 Market size, by molecule, 2018 - 2032 (USD Million)
- 10.4.12.4 Market size, by usage, 2018 - 2032 (USD Million)
- 10.4.12.5 Market size, by end-use, 2018 - 2032 (USD Million)
- 10.5 Latin America
- 10.5.1 Market size, by country, 2018 - 2032 (USD Million)
- 10.5.2 Market size, by product type, 2018 - 2032 (USD Million)
- 10.5.3 Market size, by cell, 2018 - 2032 (USD Million)
- 10.5.4 Market size, by molecule, 2018 - 2032 (USD Million)
- 10.5.5 Market size, by usage, 2018 - 2032 (USD Million)
- 10.5.6 Market size, by end-use, 2018 - 2032 (USD Million)
- 10.5.7 Brazil
- 10.5.7.1 Market size, by product type, 2018 - 2032 (USD Million)
- 10.5.7.2 Market size, by cell, 2018 - 2032 (USD Million)
- 10.5.7.3 Market size, by molecule, 2018 - 2032 (USD Million)
- 10.5.7.4 Market size, by usage, 2018 - 2032 (USD Million)
- 10.5.7.5 Market size, by end-use, 2018 - 2032 (USD Million)
- 10.5.8 Mexico
- 10.5.8.1 Market size, by product type, 2018 - 2032 (USD Million)
- 10.5.8.2 Market size, by cell, 2018 - 2032 (USD Million)
- 10.5.8.3 Market size, by molecule, 2018 - 2032 (USD Million)
- 10.5.8.4 Market size, by usage, 2018 - 2032 (USD Million)
- 10.5.8.5 Market size, by end-use, 2018 - 2032 (USD Million)
- 10.6 Middle East & Africa
- 10.6.1 Market size, by country, 2018 - 2032 (USD Million)
- 10.6.2 Market size, by product type, 2018 - 2032 (USD Million)
- 10.6.3 Market size, by cell, 2018 - 2032 (USD Million)
- 10.6.4 Market size, by molecule, 2018 - 2032 (USD Million)
- 10.6.5 Market size, by usage, 2018 - 2032 (USD Million)
- 10.6.6 Market size, by end-use, 2018 - 2032 (USD Million)
- 10.6.7 South Africa
- 10.6.7.1 Market size, by product type, 2018 - 2032 (USD Million)
- 10.6.7.2 Market size, by cell, 2018 - 2032 (USD Million)
- 10.6.7.3 Market size, by molecule, 2018 - 2032 (USD Million)
- 10.6.7.4 Market size, by usage, 2018 - 2032 (USD Million)
- 10.6.7.5 Market size, by end-use, 2018 - 2032 (USD Million)
- 10.6.8 UAE
- 10.6.8.1 Market size, by product type, 2018 - 2032 (USD Million)
- 10.6.8.2 Market size, by cell, 2018 - 2032 (USD Million)
- 10.6.8.3 Market size, by molecule, 2018 - 2032 (USD Million)
- 10.6.8.4 Market size, by usage, 2018 - 2032 (USD Million)
- 10.6.8.5 Market size, by end-use, 2018 - 2032 (USD Million)
Chapter 11 Company Profiles
- 11.1 Applikon Biotechnology, Inc. (Getinge)
- 11.1.1 Business overview
- 11.1.2 Financial data
- 11.1.3 Product landscape
- 11.1.4 Strategic outlook
- 11.1.5 SWOT analysis
- 11.2 Bbi Biotech
- 11.2.1 Business overview
- 11.2.2 Financial data
- 11.2.3 Product landscape
- 11.2.4 Strategic outlook
- 11.2.5 SWOT analysis
- 11.3 Cellexus Ltd
- 11.3.1 Business overview
- 11.3.2 Financial data
- 11.3.3 Product landscape
- 11.3.4 Strategic outlook
- 11.3.5 SWOT analysis
- 11.4 CerCell ApS
- 11.4.1 Business overview
- 11.4.2 Financial data
- 11.4.3 Product landscape
- 11.4.4 Strategic outlook
- 11.4.5 SWOT analysis
- 11.5 CESCO Bioengineering Co. Ltd.
- 11.5.1 Business overview
- 11.5.2 Financial data
- 11.5.3 Product landscape
- 11.5.4 Strategic outlook
- 11.5.5 SWOT analysis
- 11.6 Eppendorf AG
- 11.6.1 Business overview
- 11.6.2 Financial data
- 11.6.3 Product landscape
- 11.6.4 Strategic outlook
- 11.6.5 SWOT analysis
- 11.7 GEA Group Aktiengesellschaft
- 11.7.1 Business overview
- 11.7.2 Financial data
- 11.7.3 Product landscape
- 11.7.4 Strategic outlook
- 11.7.5 SWOT analysis
- 11.8 Merck Group
- 11.8.1 Business overview
- 11.8.2 Financial data
- 11.8.3 Product landscape
- 11.8.4 Strategic outlook
- 11.8.5 SWOT analysis
- 11.9 Danaher Corporation
- 11.9.1 Business overview
- 11.9.2 Financial data
- 11.9.3 Product landscape
- 11.9.4 Strategic outlook
- 11.9.5 SWOT analysis
- 11.10 PBS Biotech
- 11.10.1 Business overview
- 11.10.2 Financial data
- 11.10.3 Product landscape
- 11.10.4 Strategic outlook
- 11.10.5 SWOT analysis
- 11.11 Pierre Guerin Sas (Engie)
- 11.11.1 Business overview
- 11.11.2 Financial data
- 11.11.3 Product landscape
- 11.11.4 Strategic outlook
- 11.11.5 SWOT analysis
- 11.12 Sartorius Stedim Biotech Group
- 11.12.1 Business overview
- 11.12.2 Financial data
- 11.12.3 Product landscape
- 11.12.4 Strategic outlook
- 11.12.5 SWOT analysis
- 11.13 Shanghai Bailun Biotechnology Co. Ltd.,
- 11.13.1 Business overview
- 11.13.2 Financial data
- 11.13.3 Product landscape
- 11.13.4 Strategic outlook
- 11.13.5 SWOT analysis
- 11.14 Solaris Biotech Solutions
- 11.14.1 Business overview
- 11.14.2 Financial data
- 11.14.3 Product landscape
- 11.14.4 Strategic outlook
- 11.14.5 SWOT analysis
- 11.15 Thermo Fisher Scientific
- 11.15.1 Business overview
- 11.15.2 Financial data
- 11.15.3 Product landscape
- 11.15.4 Strategic outlook
- 11.15.5 SWOT analysis